Cynvenio Biosystems Revenue and Competitors
Estimated Revenue & Valuation
- Cynvenio Biosystems's estimated annual revenue is currently $2.9M per year. 0
- Cynvenio Biosystems's total funding is $45.8M.
Employee Data
- 00
Cynvenio Biosystems's People
| Name | Title | Email/Phone |
|---|
Cynvenio Biosystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cynvenio Biosystems?
Cynvenio Biosystems Inc. is a privately funded start-up based in Westlake Village, California. The company was founded in 2006 on the strength of the technology developed by Prof. H. (Tom) Soh’s lab at the University of California, Santa Barbara (UCSB) and a development contract funded by the US Army Research Laboratories (ARL) via the Institute for Collaborative Biotechnologies (ICB).Cynvenio Biosystems is advancing the vision of personalized medicine by developing high performance instruments and assays that support the R&D market in life sciences. Our proprietary instrumentation, sample handling, cell sorting, detection, and amplification technology enables the work of organizations focusing on cancer research, stem cells and the discovery and validation of novel therapeutic solutions. Launched in 2006, Cynvenio is privately funded and is based in Westlake Village, California.
keywords:N/A
$45.8M
Total Funding
N/A
Number of Employees
$2.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cynvenio Biosystems News
Cynvenio Biosystems; Exosome Diagnostics; F. Hoffmann-La Roche; Clearbridge BioMedics; Bio-Rad Laboratories; Agena Bioscience; Cancer Genetics...
... Biosystems, Thermo Fisher Scientific., Siemens, Biocept, Inc., Bio-Rad Laboratories, Inc., Fluxion Biosciences, Inc., Cynvenio AI, Inc.,...
Cynvenio Biosystems Exosome Diagnostics F. Hoffmann-La Roche Clearbridge BioMedics. Bio-Rad Laboratories Agena Bioscience Cancer Genetics
Cynvenio Biosystems, Inc., a Westlake Village, California-based developer of LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies, completed a $25.5m Series B equity financing. The round was led by Livzon Pharmaceuti ...
Westlake Village-based Cynvenio Biosystems said Wednesday that it has raised $25.5M in a Series B funding round. The developer of life sciences equipment, used to profile cancer cells circulating in whole blood, came from Livzon Pharmaceutical Group, along with Greenwoods Private Equity Funds an ...
Other Companies in Thousand Oaks
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $75.7M | 0 | N/A | N/A |
#2 | N/A | 1 | -99% | N/A |
#3 | $0.1M | 1 | -50% | N/A |
#4 | $0.1M | 1 | -75% | N/A |
#5 | $0.1M | 1 | -92% | N/A |